Management of smoking cessation in patients with psychiatric disorders

被引:72
作者
Fagerstrom, Karl [1 ]
Aubin, Henri-Jean [2 ,3 ,4 ]
机构
[1] Fagerstrom Consulting AB, Smokers Informat Ctr, S-25452 Helsingborg, Sweden
[2] Hop Emile Roux, AP HP, Limeil Brevannes, France
[3] Hop Paul Brousse, Ctr Enseignement Rech & Traitement Addict, Paris, France
[4] AP HP, Villejuif, France
关键词
Depression; Nicotine withdrawal; Psychiatric disorders; Schizophrenia; Smoking cessation; CIGARETTE-SMOKING; NICOTINE DEPENDENCE; TOBACCO DEPENDENCE; DEPRESSED SMOKERS; MAJOR DEPRESSION; MENTAL-ILLNESS; SCHIZOPHRENIA; SYMPTOMS; WITHDRAWAL; ALCOHOL;
D O I
10.1185/03007990802707568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is a close relationship between tobacco smoking and psychiatric disorders, and a higher proportion of individuals with mental health conditions smoke compared with the general population. Due to the increased smoking prevalence in this population, patients with psychiatric conditions are at greater risk of smoking-related morbidity and mortality and experience detrimental effects on their quality of life. However, while the majority of individuals with a history of mental health conditions appreciate that smoking is detrimental to their health, they are less likely to quit smoking and have a lower success rate during quit attempts compared with the general population. Scope: Peer-reviewed articles were identified from PubMed using the inclusive date-range of 1990-October 2008 and the search terms; depression, mental health, psychiatric disorders, schizophrenia, and smoking cessation. Articles were selected from the search results to provide a general overview of some of the main issues for smokers with psychiatric disorders in general and specifically, those with schizophrenia and depression. The evidence from smoking cessation trials within these populations was also reviewed. Findings: Nicotine has some positive effects on symptoms of psychiatric disorders and it has been proposed that patients with mental health conditions may smoke as a form of self-medication. Further, several studies have shown that some symptoms of psychiatric disorders may be exacerbated by nicotine withdrawal. Therefore, attempts to quit smoking pose additional problems to patients with mental health problems. Conclusion: Traditional programmes for smoking cessation may not always be suitable for psychiatric patients due to their neuropsychological profile. Preliminary evidence suggests that more flexible, open-ended, combination approaches of pharmacotherapy and counselling may be more successful. In addition, identification and treatment of nicotine addiction remains very low in patients with mental health conditions and far more needs to be done to raise the awareness and ability of psychiatrists to diagnose and treat patients with nicotine problems.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 61 条
[1]   Schizophrenia, sensory gating, and nicotinic receptors [J].
Adler, LE ;
Olincy, A ;
Waldo, M ;
Harris, JG ;
Griffith, J ;
Stevens, K ;
Flach, K ;
Nagamoto, H ;
Bickford, P ;
Leonard, S ;
Freedman, R .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202
[2]   Characteristics of smokers with a psychotic disorder and implications for smoking interventions [J].
Baker, Amanda ;
Richmond, Robyn ;
Haile, Melanie ;
Lewin, Terry J. ;
Carr, Vaughan J. ;
Taylor, Rachel L. ;
Constable, Paul M. ;
Jansons, Sylvia ;
Wilhelm, Kay ;
Moeller-Saxone, Kristen .
PSYCHIATRY RESEARCH, 2007, 150 (02) :141-152
[3]   Pharmacology of nicotine: Addiction and therapeutics [J].
Benowitz, NL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :597-613
[4]  
Binkin N, 2007, INT J TUBERC LUNG D, V11, P522
[5]   Depression following smoking cessation in women [J].
Bock, BC ;
Goldstein, MC ;
Marcus, BH .
JOURNAL OF SUBSTANCE ABUSE, 1996, 8 (01) :137-144
[6]   Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder [J].
Broocks, A ;
Bandelow, B ;
Koch, K ;
Bartmann, U ;
Kinkelbur, J ;
Schweiger, U ;
Hohagen, F ;
Hajak, G .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (02) :270-278
[7]   Bupropion and cognitive-behavioral treatment for depression in smoking cessation [J].
Brown, Richard A. ;
Niaura, Raymond ;
Lloyd-Richardson, Elizabeth E. ;
Strong, David R. ;
Kahler, Christopher W. ;
Abrantes, Ana M. ;
Abrams, David ;
Miller, Ivan W. .
NICOTINE & TOBACCO RESEARCH, 2007, 9 (07) :721-730
[8]   Causes of the excess mortality of schizophrenia [J].
Brown, S ;
Inskip, H ;
Barraclough, B .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :212-217
[9]  
Campion J., 2008, ADV PSYCHIAT TREATME, V14, P217, DOI DOI 10.1192/APT.BP.108.005710
[10]   Implementing smoke-free policies in mental health inpatient units: learning from unsuccessful experience [J].
Campion, Jonathan ;
Lawn, Sharon ;
Brownlie, Andrew ;
Hunter, Ernest ;
Gynther, Bruce ;
Pols, Rene .
AUSTRALASIAN PSYCHIATRY, 2008, 16 (02) :92-97